Evidence map›Paper›PMID 40661452›Full record

ArticlebioRxiv : the preprint server for biology2025

Longitudinal single cell RNA-sequencing reveals evolution of micro- and macro-states in chronic myeloid leukemia.

David E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, Anupam Dey, Ziang Chen, Jihyun Irizarry, Jennifer Rangel Ambriz, Sergio Branciamore, Denis O'Meally, Lucy Ghoda and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

David E FrankhouserDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0002-8233-5853
Dandan ZhaoDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.
Yu-Hsuan FuDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.
Anupam DeyDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0000-0002-9071-8774
Ziang ChenDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, 91010, USA.
Jihyun IrizarryDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.
Jennifer Rangel AmbrizDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, 91010, USA.
Sergio BranciamoreDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0002-2556-8765
Denis O'MeallyDepartment of Diabetes & Cancer Discovery Science, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0001-7749-9506
Lucy GhodaDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0002-8212-3586
Jeffery M TrentTranslational Genomics Institute, Phoenix, Arizona, 85004, USA.
Stephen FormanDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.
Adam L MacLeanDepartment of Quantitative and Computational Biology, University of Southern California, Los Angeles, California, 90089, USA.ORCID 0000-0003-0689-7907
Ya-Huei KuoDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0003-2595-0419
Bin ZhangDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.
Russell C RockneDepartment of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0002-1557-159X
Guido MarcucciDepartment of Hematologic Malignancies Translational Science, Beckman Research Institute and Division of Leukemia, City of Hope National Medical Center, Duarte, California, 91010, USA.ORCID 0000-0002-3983-5908

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI STANLEY R. HAMILTON · 1985 to 2026
$86.3M
Information flow and state transitions at the system and multi-dimensional scales in leukemia progressionU01CA250046 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI KUO, YA-HUEI, MARCUCCI, GUIDO · 2020 to 2024
$3.6M
Cancer Metabolism Training ProgramT32CA221709 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI David K. Ann, Victoria L. Seewaldt · 2018 to 2026
$1.8M
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapyU01CA293853 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI YA-HUEI KUO, GUIDO MARCUCCI · 2024 to 2026
$1.8M
NCI NIH HHS P30 CA033572NCI NIH HHS T32 CA221709NCI NIH HHS U01 CA250046NCI NIH HHS U01 CA293853
6 · The paper itself

Abstract

Single cell RNA sequencing (scRNA-seq) has revolutionized our understanding of cancer, yet identifying meaningful disease states from single cell data remains challenging. Here, we systematically explore the cancer specific information content encoded in single cell versus bulk transcriptomics to resolve this paradox and clarify how discrete disease-defining states emerge from inherently noisy single cell data. Using chronic myeloid leukemia (CML) progression as a model, we demonstrate that, while single cell transcriptomes exist along continuous transcriptional microstates, clinically relevant leukemia phenotypes clearly manifest only at the pseudobulk (macrostate) level. By leveraging state-transition theory, we reveal how robust disease phenotype state-transitions are governed by cell type specific contributions. Our results establish a theoretical framework explaining why discrete disease phenotypes remain hidden at the single cell scale but emerge clearly at the aggregated macrostate level, enabling previously inaccessible biological insights into leukemia evolution. Broadly applicable across cancers and other complex diseases, our approach fundamentally advances single cell analysis by clarifying how microscopic transcriptional variation collectively shapes macroscopic disease dynamics.

Indexed as

cell stateCMLevolutioninformation contentmicrostatesingle cell RNA sequencing (scRNA-seq)state-transitionsystem epigenetics

Identifiers

PMID40661452
PMCPMC12258802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.